| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 06/22/1999 | US5914314 Hyaluronic acid and its nontoxic salts facilitate penetration of immunosuppressent through underperfused or pathological tissue, including scar tissue |
| 06/22/1999 | US5914112 Anti-CD18 antibodies in stroke |
| 06/22/1999 | CA2169066C Phenoxyphenyl cyclopentenyl hydroxyureas |
| 06/22/1999 | CA2019614C Antihypertensives and food and drinks |
| 06/22/1999 | CA1340608C Alkoxy-4(1h)-pyridone derivatives, processes for the preparation thereof and pharmaceutical compositions containing them |
| 06/20/1999 | CA2255143A1 Binding partners for inhibitors of cyclin-dependent kinases and their use for searching for inhibitors and for the diagnosis or therapy of a disease |
| 06/20/1999 | CA2255141A1 Nucleic acid constructs for gene therapy whose activity is affected by inhibitors of cyclin-dependent kinases |
| 06/17/1999 | WO1999030157A2 Neuropilins in methods for diagnosis and prognosis of cancer |
| 06/17/1999 | WO1999029878A2 Methods of producing anti-angiogenic proteins: endostatin, angiostatin or restin, using a pichia yeast expression system |
| 06/17/1999 | WO1999029861A1 Peptide antagonists of vascular endothelial growth factor |
| 06/17/1999 | WO1999029856A1 Restin and methods of use thereof |
| 06/17/1999 | WO1999029855A1 Mutants of endostatin, 'em 1' having anti-angiogenic activity and methods of use thereof |
| 06/17/1999 | WO1999029841A1 Purification and microsequencing of hyaluronidase isozymes |
| 06/17/1999 | WO1999029697A1 Pharmaceuticals |
| 06/17/1999 | WO1999029685A1 (e)-3-[1-n-butyl- 5-[2-(2-carboxyphenyl)methoxy- 4-chlorophenyl]-1h- pyrazol-4-yl]-2-[(5- methoxy-2,3- dihydrobenzofuran-6-yl)methyl]- prop-2-enoic acid monoargininyl salt |
| 06/17/1999 | WO1999029669A1 Urethanes derived from azacycloalkanes, thio and dithio analogues, production and use thereof as 2,3 epoxysqualene lanesterol cyclase inhibitors |
| 06/17/1999 | WO1999029667A1 Hydroxamic acid derivatives as matrix metalloprotease (mmp) inhibitors |
| 06/17/1999 | WO1999029662A2 Urethanes, thio and dithio analogues, the salts thereof, medicaments containing said compounds, use and method for the production thereof |
| 06/17/1999 | WO1999029655A1 Novel antiarrhythmic compounds |
| 06/17/1999 | WO1999029346A1 Pharmaceutical composition for treating cerebral apoplexy and craniocerebral trauma |
| 06/17/1999 | WO1999029336A1 Glp-1 formulations |
| 06/17/1999 | WO1999029331A1 The use of phospholipid complexes of extracts of vitis vinifera as anti-atherosclerotic agents |
| 06/17/1999 | WO1999029316A1 Pharmaceutical compositions containing an omega-3 fatty acid oil |
| 06/17/1999 | WO1999029308A2 Method for combating obesity |
| 06/17/1999 | WO1999017742A3 Taste masked formulations |
| 06/17/1999 | WO1999015548A3 Isolated and recombinant antimicrobial peptides thrombocidin-1 (tc-1) and thrombocidin-2 (tc-2) or variants thereof |
| 06/17/1999 | WO1998018823A8 Ice inhibiting peptides |
| 06/17/1999 | DE19755800A1 Cyclopeptidderivate Cyclopeptide derivatives |
| 06/17/1999 | DE19755268A1 Benzamidinderivate Benzamidine derivatives |
| 06/17/1999 | DE19754796A1 Neue, von Azacycloalkanen abgeleitete Urethane, ihre Thio- und Dithioanaloga, deren Salze, diese Verbindungen enthaltende Arzneimittel und deren Verwendung sowie Verfahren zu ihrer Herstellung New-derived azacycloalkanes urethanes, their thio and Dithioanaloga, salts thereof, pharmaceutical compositions containing them and their use, and processes for their preparation |
| 06/17/1999 | DE19754795A1 Neue Urethane, ihre Thio- und Dithioanaloga, deren Salze, diese Verbindungen enthaltende Arzneimittel und deren Verwendung sowie Verfahren zu ihrer Herstellung New urethanes, their thio and Dithioanaloga, salts thereof, pharmaceutical compositions containing them and their use, and processes for their preparation |
| 06/17/1999 | CA2313705A1 Restin and methods of use thereof |
| 06/17/1999 | CA2313390A1 Peptide antagonists of vascular endothelial growth factor |
| 06/17/1999 | CA2313251A1 Mutants of endostatin, "em 1" having anti-angiogenic activity and methods of use thereof |
| 06/17/1999 | CA2313191A1 Novel antiarrhythmic compounds |
| 06/17/1999 | CA2312965A1 (e)-3-¬1-n-butyl-5-¬2-(2-carboxyphenyl)methoxy-4-chlorophenyl|-1h-pyrazol-4-yl|-2-¬(5-methoxy-2,3-dihydrobenzofuran-6-yl)methyl|-prop-2-enoic acid monoargininyl salt |
| 06/17/1999 | CA2312844A1 Pharmaceuticals |
| 06/17/1999 | CA2312287A1 Methods of producing anti-angiogenic proteins: endostatin, angiostatin or restin, using a pichia yeast expression system |
| 06/17/1999 | CA2312190A1 Glp-1 formulations |
| 06/17/1999 | CA2311283A1 Purification and microsequencing of hyaluronidase isozymes |
| 06/17/1999 | CA2309388A1 New urethanes derived from azacycloalkanes, the thio and dithio analogues thereof, the salts thereof, pharmaceutical compositions containing these compounds and their use as well as processes for preparing them |
| 06/16/1999 | EP0922454A2 Arginine antagonists for inhibition of systemic hypotension associated with nitric oxide production or endothelial derived relaxing factor |
| 06/16/1999 | EP0922107A1 Human kallikrein |
| 06/16/1999 | EP0922044A1 Pyrrolo(3,2-c) quinoline derivatives |
| 06/16/1999 | EP0922039A1 Cyclic carbamates and isoxazolidines as iib/iiia antagonists |
| 06/16/1999 | EP0921815A1 Therapeutic uses of humanized antibodies against alpha-4 integrin |
| 06/16/1999 | EP0921801A1 Inhibitors of farnesyl-protein transferase |
| 06/16/1999 | EP0921800A1 Substituted biphenyl isoxazole sulfonamides |
| 06/16/1999 | EP0921798A1 Novel treatment of leptine resistance |
| 06/16/1999 | EP0749582B1 Methods of diagnosing preeclampsia |
| 06/16/1999 | EP0583421B1 Substituted dibenzoxazepine compounds, pharmaceutical compositions and methods of use |
| 06/16/1999 | EP0528922B1 New sulfonyl compounds |
| 06/16/1999 | CN1219935A Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase |
| 06/16/1999 | CN1219929A Urea derivatives as inhibitors of IMPDH enzyme |
| 06/16/1999 | CN1219928A Novel vitamin D analogues |
| 06/16/1999 | CN1219872A Compositions and method for treating or preventing diseases of body passageways |
| 06/16/1999 | CN1219533A Sulfonamide-substituted fused 5-membered ring compounds, their use as medicament, and pharmaceutical preparation comprising them |
| 06/16/1999 | CN1043641C Hydroisoquinoline derivatives |
| 06/16/1999 | CN1043609C Process for preparing pharmaceutical composition containing benzothiazole compounds |
| 06/15/1999 | US5912360 Dioxolane intermediates |
| 06/15/1999 | US5912348 Isomerization promoted with bases |
| 06/15/1999 | US5912335 A polynucleotide sequence that codes human 7-transmembrane receptor protein; treatment of infections, hiv, eating disorders, cancers, heart diseases, mental illnesses, huntington's disease, tourett's and parkinson's disease |
| 06/15/1999 | US5912246 Treatment for schizophenia, psychosis and other psychological disorders; dopamine antagonists |
| 06/15/1999 | US5912244 Muscle disorders, breathing disorders and urinary incontinence |
| 06/15/1999 | US5912168 CD95 regulatory gene sequences |
| 06/15/1999 | US5912159 An isolated human polypeptide which controls nitric oxide biosynthesis; diagnosis and therapy for urea cycle diseases, hypertension, hypotension, prostate cancer/ hyperplasia/ hypertrophy and kidney diseases |
| 06/15/1999 | US5912144 A polypeptide having an amino acid sequence for an immediate early response gene/g protein couplec receptor; anticarcinogenic, antiproliferative and antitumor agents |
| 06/15/1999 | US5912143 Polynucleotides encoding a human mage protein homolog |
| 06/15/1999 | CA2191947C Pirydyl imidazole derivatives and processes for the preparation thereof |
| 06/15/1999 | CA2182477C Pyridyl imidazole derivatives and processes for the preparation thereof |
| 06/15/1999 | CA2087032C Diphenylmethyl piperazine derivatives |
| 06/10/1999 | WO1999028493A2 Method for identifying inhibitors of g-protein coupled receptor hibef51 |
| 06/10/1999 | WO1999028492A1 A method of finding agonist and antagonist to human 11cb splice variant |
| 06/10/1999 | WO1999028469A1 Compositions and methods for inducing gene expression |
| 06/10/1999 | WO1999028342A2 Low-voltage activated calcium channel compositions and methods |
| 06/10/1999 | WO1999028325A1 Thienopyrimidines |
| 06/10/1999 | WO1999028315A1 Imidazole derivatives having an inhibitory activity for farnesyl transferase and process for preparation thereof |
| 06/10/1999 | WO1999028309A1 1,3,4-thiadiazoles derivatives as kyn-oh inhibitors |
| 06/10/1999 | WO1999028304A2 Pdgf receptor kinase inhibitory compounds, their preparation and compositions |
| 06/10/1999 | WO1999028300A1 Substituted imidazole derivatives having agonist-like activity at alpha 2b or 2b/2c adrenergic receptors |
| 06/10/1999 | WO1999027962A1 Use of a fibrinogen receptor-antagonist for preventing disseminated intravascular coagulation |
| 06/10/1999 | WO1999027890A2 A process for the preparation of ring-opened epothilone intermediates which are useful for the preparation of epothilone analogs |
| 06/10/1999 | WO1999007737A3 Lsr receptor, cloning and uses |
| 06/10/1999 | WO1999005175A3 Diagnosis and treatment of diseases using anti-anti-t-cell receptor vbeta anti-bodies or peptides which are recognized by said antibodies, and endocrine secretion regulatory protein i (esrp1) |
| 06/10/1999 | DE19754573A1 Pharmazeutische Zusammensetzung zur Behandlung von Schlaganfall und Schädel-Hirn-Trauma A pharmaceutical composition for the treatment of stroke and traumatic brain injury |
| 06/10/1999 | DE19754082A1 Methode zur Bekämpfung der Fettleibigkeit Method to combat obesity |
| 06/10/1999 | DE19753383A1 Verwendung von Abciximab zur Behandlung von Mikrozirkulationsstörungen Use of abciximab for treatment of microcirculatory disorders |
| 06/10/1999 | CA2312824A1 Use of a fibrinogen receptor-antagonist for preventing disseminated intravascular coagulation |
| 06/10/1999 | CA2312749A1 Pdgf receptor kinase inhibitory compounds and compositions, method for synthesis of same and use of same for treatment of proliferate disorders |
| 06/10/1999 | CA2312334A1 Substituted imidazole derivatives having agonist-like activity at alpha 2b or 2b/2c adrenergic receptors |
| 06/10/1999 | CA2312195A1 Low-voltage activated calcium channel compositions and methods |
| 06/10/1999 | CA2310629A1 Imidazole derivatives having an inhibitory activity for farnesyl transferase and process for preparation thereof |
| 06/10/1999 | CA2310008A1 1,3,4-thiadiazoles derivatives as kyn-oh inhibitors |
| 06/09/1999 | EP0921124A1 Benzothiophene derivatives useful in therapy |
| 06/09/1999 | EP0921117A2 Acylguanidines |
| 06/09/1999 | EP0920872A1 Use of rosmarinus officinalis for treating various diseases |
| 06/09/1999 | EP0920515A1 A NOVEL HUMAN mRNA EDITING ENZYME |
| 06/09/1999 | EP0920444A1 C-TERMINAL MODIFIED (N-SUBSTITUTED)-2-INDOLYL DIPEPTIDES AS INHIBITORS OF THE ICE/ced-3 FAMILY OF CYSTEINE PROTEASES |
| 06/09/1999 | EP0920438A2 N6 heterocyclic substituted adenosine derivatives |
| 06/09/1999 | EP0920431A1 Thienopyrimidines |